Blood pressure

Prescription Drug Valsartan Recall

Valsartan, also known as Diovan is prescribed for high blood pressure and heart failure. It is manufactured and distributed by many different pharmaceutical companies including Teva Pharmaceuticals, Alembic Pharmaceuticals, Novartis, Zhejiang Huahai, Camber Pharmaceuticals, and Prinston Pharmaceutical among others.

On July 13, 2018, the FDA began recalling Valsartan because it was discovered that many prescriptions of Valsartan had been contaminated with a chemical, N-nitrosodimethylamine (NDMA), a known carcinogen. The specific Valsartan being recalled has been linked to liver damage (fibrosis, scarring, abnormal liver function tests) along with kidney and liver tumors – both malignant and benign. The longer someone used the contaminated Valsartan, the more likely the user is to develop these catastrophic injuries.

Forester Haynie is currently investigating Valsartan cases involving:

  1. Stomach cancer
  2. Kidney cancer, kidney tumors
  3. Intestinal tract cancer – colon / colorectal
  4. Liver cancer, liver tumors, liver injuries
  5. Bladder cancer
  6. Pancreatic cancer

If you or a loved one developed digestive tract, liver, pancreatic or kidney problems anytime after January 1, 2010, then contact Forester Haynie as soon as possible. In fact, click the link below to have one of our experienced attorneys start working on your case immediately.

Get started now.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *